Hangzhou AGS Medtech (688581.SH) actual controller proposes to repurchase company shares for RMB 35 million to RMB 70 million.

Hangzhou AGS Medtech (688581.SH) announced that on September 22, 2026, the company's board of directors received a letter from Mr. Zhang Cheng, the company's actual controller, chairman, and general manager, proposing the repurchase of company shares by Hangzhou AGS Medtech Medical Technology Co., Ltd. Mr. Zhang Cheng proposed that the company use the excess funds raised from its initial public offering of RMB ordinary shares to repurchase part of its already-issued RMB ordinary shares (A shares) through the Shanghai Stock Exchange trading system by way of centralized bidding. The total repurchase amount shall be no less than RMB 35 million and no more than RMB 70 million, and the repurchased shares will be used for an employee stock ownership plan or equity incentive.